Arfuso Francesca, Bazzano Marilena, Brianti Emanuele, Gaglio Gabriella, Passantino Annamaria, Tesei Beniamino, Laus Fulvio
Department of Veterinary Sciences, University of Messina, Messina, Italy.
School of Biosciences and Veterinary Medicine, University of Camerino, Macerata, Italy.
Front Vet Sci. 2020 Nov 5;7:556270. doi: 10.3389/fvets.2020.556270. eCollection 2020.
The increasing levels of anthelmintic resistance together with the restrictions in the use of drugs in food producing animals have enforced the search for sustainable alternative approaches for parasite control. The current study aimed to investigate the safety and the efficacy of a commercially available phytotherapic formulation against gastrointestinal strongyles in donkeys. Twenty-two Ragusana jennies (2.6 ± 0.5 years old) were assigned to two equal groups. One group was treated with two doses of a phytotherapic supplement Paraxitebio® containing , and , 14 days apart (Group A). One group was used as negative control (Group B). Individual fecal samples were collected at the beginning of the study (T), and after 7, 14, and 28 days (T, T, T). Blood samples were collected on T and T in order to assess changes in donkeys' hematological profile. After the initial rise in EPG values observed on T, Group A showed a significant EPG decrease with lower eggs per gram (EPG) count compared to Group B on T and an overall fecal egg count reduction of 56.9% on the same time-point. Hematological parameters were within the normal physiological ranges for enrolled donkeys. However, significant differences in the values of RBCs, Hb, MCHC, MCV, WBCs, eosinophils, and basophils were recorded between groups after phytotherapic treatments, with Group A showing a general improvement in the hemogram picture. The phytotherapic supplement used in the current study was helpful in controlling intestinal parasites allowing a significant reduction in the fecal egg count 28 days after treatment. Further studies are needed to better explore the specific mode of action of the plant-derived formulation herein tested as well as to encourage their use as tool for the control of equine strongylosis under multimodal integrated approach in dairy donkey farms.
驱虫抗性水平的不断提高以及食品生产动物用药限制,促使人们寻求可持续的寄生虫控制替代方法。本研究旨在调查一种市售植物疗法制剂对驴胃肠道圆线虫的安全性和有效性。将22头拉古萨纳母驴(2.6±0.5岁)分为两组,每组数量相等。一组用两剂含有[具体成分未给出]的植物疗法补充剂Paraxitebio®进行治疗,间隔14天(A组)。一组用作阴性对照(B组)。在研究开始时(T0)以及7天、14天和28天后(T7、T14、T28)收集个体粪便样本。在T0和T28采集血样,以评估驴血液学指标的变化。在T7观察到EPG值最初上升后,A组的EPG显著下降,与B组相比,T14时每克粪便虫卵数(EPG)更低,且在同一时间点粪便虫卵总数总体减少了56.9%。血液学参数在纳入研究的驴的正常生理范围内。然而,植物疗法治疗后两组之间红细胞、血红蛋白、平均红细胞血红蛋白浓度、平均红细胞体积、白细胞、嗜酸性粒细胞和嗜碱性粒细胞的值存在显著差异,A组的血常规情况总体有所改善。本研究中使用的植物疗法补充剂有助于控制肠道寄生虫,使治疗后28天粪便虫卵数显著减少。需要进一步研究,以更好地探索本文测试的植物源制剂的具体作用方式,并鼓励在奶驴养殖场的多模式综合方法下将其用作控制马属动物圆线虫病的工具。